Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of Hepatocellular Carcionoma.

NCT06134973 is registered in ClinicalTrials.gov with Tianjin Third Central Hospital as lead sponsor.

NCT NCT06134973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06134973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of Hepatocellular Carcionoma.
Lead sponsor
Tianjin Third Central Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
June 30, 2025
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma